SEC Form 4 · accession 0001127602-18-000936
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James C Foster
Officer — Chairman, President and CEO · Director
Period of report
Jan 2, 2018
Accepted (ET)
Jan 4, 2018 · 11:17 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 2, 2018 | S | 600 | $110.36 | D | 298,131 | D | |
| Common Stock | Jan 2, 2018 | S | 100 | $110.365 | D | 298,031 | D | |
| Common Stock | Jan 2, 2018 | S | 400 | $110.37 | D | 297,631 | D | |
| Common Stock | Jan 2, 2018 | S | 75 | $110.38 | D | 297,556 | D | |
| Common Stock | Jan 2, 2018 | S | 100 | $110.385 | D | 297,456 | D | |
| Common Stock | Jan 2, 2018 | S | 100 | $110.39 | D | 297,356 | D | |
| Common Stock | Jan 2, 2018 | S | 90 | $110.415 | D | 297,266 | D | |
| Common Stock | Jan 2, 2018 | S | 200 | $110.42 | D | 297,066 | D | |
| Common Stock | Jan 2, 2018 | S | 400 | $110.43 | D | 296,666 | D | |
| Common Stock | Jan 2, 2018 | S | 38 | $110.445 | D | 296,628 | D | |
| Common Stock | Jan 2, 2018 | S | 62 | $110.45 | D | 296,566 | D | |
| Common Stock | Jan 2, 2018 | S | 100 | $110.455 | D | 296,466 | D | |
| Common Stock | Jan 2, 2018 | S | 200 | $110.475 | D | 296,266 | D | |
| Common Stock | Jan 2, 2018 | S | 400 | $110.50 | D | 295,866 | D | |
| Common Stock | Jan 2, 2018 | S | 400 | $109.46 | D | 295,466 | D | |
| Common Stock | Jan 2, 2018 | S | 200 | $110.55 | D | 295,266 | D | |
| Common Stock | holding | — | — | — | 340 | I | By Trust | |
| Common Stock | holding | — | — | — | 10,000 | I | Held By Spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.